The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Self-citationRantapää‐Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U., & van Venrooij, W. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,953
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
ANKYLOSING SPONDYLITIS AND HL-A 27
Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. O., & Sturrock, R. D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91360-3 · Cited by 1,836
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis
Stastny, P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804202981602 · Cited by 1,163
BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells
O'Connor, B. P., Raman, V. S., Erickson, L. D., Cook, W. J., Weaver, L. K., Ahonen, C., Lin, L.-L., Mantchev, G. T., Bram, R. J., & Noelle, R. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031330 · Cited by 1,128
BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF
Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C., Schneider, P., Sizing, I. D., Mullen, C., et al. (2001) · Science · doi:10.1126/science.1061965 · Cited by 889
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Arend, L. J., Sloand, J. A., Rosenblatt, J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20430 · Cited by 776
RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION
Janossy, G., Duke, O., Poulter, L. W., Panayi, G., Bofill, M., & Goldstein, G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91107-7 · Cited by 655
Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Teeling, J. L. (2004) · Blood · doi:10.1182/blood-2004-01-0039 · Cited by 630 · cited 1×
“However, complement-mediated lysis and induction of apoptosis might also contribute to B-cell killin”
TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease
Gross, J. A., Dillon, S. R., Mudri, S., Johnston, J., Littau, A., Roque, R., Rixon, M., Schou, O., Foley, K. P., Haugen, H., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00183-2 · Cited by 626
Waaler, E. (1940) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1940.tb01475.x · Cited by 625
Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF
Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H.-B., & Cyster, J. G. (2004) · Immunity · doi:10.1016/s1074-7613(04)00079-2 · Cited by 577
An open study of B lymphocyte depletion in systemic lupus erythematosus
Leandro, M. J., Edwards, J. C., Cambridge, G., Ehrenstein, M. R., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10541 · Cited by 576
Self-citationComplement Activation Determines the Therapeutic Activity of Rituximab In Vivo
Di Gaetano, N., Cittera, E., Nota, R., Vecchi, A., Grieco, V., Scanziani, E., Botto, M., Introna, M., & Golay, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1581 · Cited by 576
From T to B and back again: positive feedback in systemic autoimmune disease
Shlomchik, M. J., Craft, J. E., & Mamula, M. J. (2001) · Nature Reviews Immunology · doi:10.1038/35100573 · Cited by 572
Leandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
Self-citationStasi, R., Pagano, A., Stipa, E., & Amadori, S. (2001) · Blood · doi:10.1182/blood.v98.4.952 · Cited by 549
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
Gong, Q., Ou, Q., Ye, S., Lee, W. P., Cornelius, J., Diehl, L., Lin, W. Y., Hu, Z., Lu, Y., Chen, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.817 · Cited by 543
How important are t cells in chronic rheumatoid synovitis?
Firestein, G. S., & Zvaifler, N. J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330602 · Cited by 540
The Role of Complement in the Development of Systemic Lupus Erythematosus
Manderson, A. P., Botto, M., & Walport, M. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104549 · Cited by 538
T Cell Activation in Rheumatoid Synovium Is B Cell Dependent
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4710 · Cited by 536
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
Edwards, J. C. W., & Cambridge, G. (2001) · Rheumatology · doi:10.1093/rheumatology/40.2.205 · Cited by 523
Self-citationRituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study
Pijpe, J., van Imhoff, G. W., Spijkervet, F. K. L., Roodenburg, J. L. N., Wolbink, G. J., Mansour, K., Vissink, A., Kallenberg, C. G. M., & Bootsma, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21260 · Cited by 500
The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural To Acquired Immunity
Fearon, D. T. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.127 · Cited by 474
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M. R., Salden, M., Bodman‐Smith, M., & Webster, A. D. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11181 · Cited by 470
Self-citationRituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
Anolik, J. H., Barnard, J., Cappione, A., Pugh‐Bernard, A. E., Felgar, R. E., Looney, R. J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20592 · Cited by 456
Keogh, K. A., Wylam, M. E., Stone, J. H., & Specks, U. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20718 · Cited by 450
Rituximab in the treatment of dermatomyositis: An open‐label pilot study
Levine, T. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20849 · Cited by 440
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Münchener Medizinische Wochenschrift
Kirchner, E. S. (1968) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-196803000-00020 · Cited by 417
Van Gaalen, F. A., Van Aken, J., Huizinga, T. W. J., Schreuder, G. M. T., Breedveld, F. C., Zanelli, E., Van Venrooij, W. J., Verweij, C. L., Toes, R. E. M., & De Vries, R. R. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20316 · Cited by 393
The Biology of CD20 and Its Potential as a Target for mAb Therapy
Cragg, M. S., Walshe, C. A., Ivanov, A. O., & Glennie, M. J. (2004) · Current Directions in Autoimmunity · doi:10.1159/000082102 · Cited by 364
Leandro, M. J., Cambridge, G., Edwards, J. C., Ehrenstein, M. R., & Isenberg, D. A. (2005) · Rheumatology · doi:10.1093/rheumatology/kei080 · Cited by 364
Self-citationClinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
Leandro, M. J., Edwards, J. C. W., & Cambridge, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.883 · Cited by 345
Self-citationCooper, N., Stasi, R., Cunningham‐Rundles, S., Feuerstein, M. A., Leonard, J. P., Amadori, S., & Bussel, J. B. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04889.x · Cited by 336
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease
Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., & Benoist, C. (2002) · Nature Immunology · doi:10.1038/ni772 · Cited by 329
Bohnhorst, J. Ø., Bjørgan, M. B., Thoen, J. E., Natvig, J. B., & Thompson, K. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3610 · Cited by 321
Koopman, G., Keehnen, R. M. J., Lindhout, E., Newman, W., Shimizu, Y., van Seventer, G. A., de Groot, C., & Pals, S. T. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3760 · Cited by 303
Cambridge, G., Stohl, W., Leandro, M. J., Migone, T., Hilbert, D. M., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21650 · Cited by 274
Self-citationVita, S. D., Zaja, F., Sacco, S., Candia, A. D., Fanin, R., & Ferraccioli, G. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10467 · Cited by 251
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
Levine, T. D., & Pestronk, A. (1999) · Neurology · doi:10.1212/wnl.52.8.1701 · Cited by 250
Alarcón‐Segovia, D., Tumlin, J. A., Furie, R. A., McKay, J. D., Cardiel, M. H., Strand, V., Bagin, R. G., Linnik, M. D., Hepburn, B., & LJP 394 Investigator Consortium (2003) · Arthritis & Rheumatism · doi:10.1002/art.10763 · Cited by 244
ERIKSSON, P. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01494.x · Cited by 232
Pathogenic Roles of B Cells in Human Autoimmunity
Martin, F., & Chan, A. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00112-8 · Cited by 224
Arnott, I. D. R., Nimmo, E. R., Drummond, H. E., Fennell, J., Smith, B. R. K., MacKinlay, E., Morecroft, J., Anderson, N., Kelleher, D., O'Sullivan, M., et al. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364111 · Cited by 216
Monson, N. L., Cravens, P. D., Frohman, E. M., Hawker, K., & Racke, M. K. (2005) · Archives of Neurology · doi:10.1001/archneur.62.2.258 · Cited by 210
Lindvall, J. M., Blomberg, K. E. M., Väliaho, J., Vargas, L., Heinonen, J. E., Berglöf, A., Mohamed, A. J., Nore, B. F., Vihinen, M., & Smith, C. I. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00225.x · Cited by 200
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Sidiropoulos, P. I., & Boumpas, D. T. (2004) · Lupus · doi:10.1191/0961203304lu1032oa · Cited by 178
The BAFF/APRIL System: An Important Player in Systemic Rheumatic Diseases
Mackay, F., Sierro, F., Grey, S. T., & Gordon, T. P. (2004) · Current Directions in Autoimmunity · doi:10.1159/000082106 · Cited by 176
Do self‐perpetuating B lymphocytes drive human autoimmune disease?
Edwards, Cambridge, & Abrahams (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00772.x · Cited by 174
Targeting Syk as a treatment for allergic and autoimmune disorders
Wong, B. R., Grossbard, E. B., Payan, D. G., & Masuda, E. S. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.743 · Cited by 161
Stüve, O., Cepok, S., Elias, B., Saleh, A., Hartung, H.-P., Hemmer, B., & Kieseier, B. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1620 · Cited by 149
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
Arin, M. J., Engert, A., Krieg, T. M., & Hunzelmann, N. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06651.x · Cited by 144
Abrahams, V. M., Cambridge, G., Lydyard, P. M., & Edwards, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<608::aid-anr18>3.0.co;2-g · Cited by 131
Self-citationOtipoby, K., Draves, K. E., & Clark, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105446200 · Cited by 126
Stohl, W., Xu, D., Kim, K. S., Koss, M. N., Jørgensen, T. N., Deocharan, B., Metzger, T. E., Bixler, S. A., Hong, Y. S., Ambrose, C. M., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21138 · Cited by 119
Efficacy of rituximab in refractory polymyositis.
Lambotte, O., Kotb, R. R., Maigné, G., et al. (2005) · PubMed · Cited by 112
Ebisuno, Y., Tanaka, T. T., Kanemitsu, N., Kanda, H., Yamaguchi, K., Kaisho, T., Akira, S., & Miyasaka, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1642 · Cited by 108
Hereditary Periodic Fever Syndromes
Kastner, D. L. (2005) · Hematology · doi:10.1182/asheducation-2005.1.74 · Cited by 105
New treatments for SLE: cell-depleting and anti-cytokine therapies
Anolik, J. H., & Aringer, M. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.05.006 · Cited by 101
Vallera, D. A., Todhunter, D. A., Kuroki, D. W., Shu, Y., Sicheneder, A., & Chen, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2290 · Cited by 99
van Vollenhoven, R., Gunnarsson, I., Henriksson, E. W., Sundelin, B., Österborg, A., Sh, J., & Klareskog, L. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740410010227 · Cited by 93
Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis.
Edwards, J. (2000) · Arthritis Research · doi:10.1186/ar110 · Cited by 86
Self-citationDepletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis
Vugmeyster, Y., Beyer, J. C., Howell, K., Combs, D., Fielder, P. J., Yang, J., Qureshi, F., Sandlund, B., Kawaguchi, L., Dummer, W., et al. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000155050.03916.04 · Cited by 79
Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)
Swords, R., Power, D., Fay, M., O’Donnell, R., & Murphy, P. T. (2004) · American Journal of Hematology · doi:10.1002/ajh.20135 · Cited by 67
BHATIA, BLADES, Cambridge, & EDWARDS (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00491.x · Cited by 66
TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
Maini, R. N., ELLIOTT, M., Brennan, F. M., Williams, R. O., & Feldmann, M. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb00567.x · Cited by 64
Shan, D., Press, O. W., Tsu, T. T., Hayden, M. S., & Ledbetter, J. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6589 · Cited by 63
Rouzière, A., Kneitz, C., Palanichamy, A., Dörner, T., & Tony, H. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1731 · Cited by 54
Improvement of refractory rheumatoid arthritis after depletion of B cells
Kneitz, C., Wilhelm, M., & Tony, H. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004379 · Cited by 38
Rationale for new treatments aimed at IgE immunomodulation
Stokes, J. R., & Casale, T. B. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61490-1 · Cited by 36
Memory B-cell clones and the diversity of their members
MacLennan, I. C. M., Casamayor‐Palleja, M., Toellner, K., Gulbranson‐Judge, A., & Gordon, J. (1997) · Seminars in Immunology · doi:10.1006/smim.1997.0078 · Cited by 28
B Lymphocyte Depletion Therapy in Autoimmune Disorders: Chasing Trojan Horses
Edwards, J., Cambridge, G., & Leandro, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-24534-0_21 · Cited by 1
Self-citation
Cited by
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
B lymphocytes: how they develop and function
LeBien, T. W., & Tedder, T. F. (2008) · Blood · doi:10.1182/blood-2008-02-078071 · Cited by 1,400
Immunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Metadata
- Authors
- Edwards, J. C. W., & Cambridge, G.
- Venue
- Nature Reviews Immunology
- Published
- 2006-04-07
- Volume
- 6
- Issue
- 5
- Pages
- 394-403
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1968889356
- Cited by
- 507
- References
- 80
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.